clofibric acid has been researched along with prostaglandin d2 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrera, G; Briatore, F; Dianzani, MU; Ferretti, C; Laurora, S; Pizzimenti, S | 1 |
| Aru, GM; Mujumdar, VS; Tummalapalli, CM; Tyagi, SC | 1 |
| Hunt, MJ; Tyagi, SC | 1 |
3 other study(ies) available for clofibric acid and prostaglandin d2
| Article | Year |
|---|---|
Synergistic effect of 4-hydroxynonenal and PPAR ligands in controlling human leukemic cell growth and differentiation.
Topics: Aldehydes; Cell Differentiation; Cell Division; Chromans; Clofibrate; Clofibric Acid; Drug Synergism; Fibric Acids; HL-60 Cells; Humans; Ligands; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Troglitazone; U937 Cells | 2002 |
Mechanism of constrictive vascular remodeling by homocysteine: role of PPAR.
Topics: Antineoplastic Agents; Aorta; Cell Culture Techniques; Clofibric Acid; Collagen; Culture Media, Serum-Free; Disintegrins; Endothelium, Vascular; Fibric Acids; Homocysteine; Humans; Metalloendopeptidases; Muscle, Smooth; Peroxisome Proliferators; Platelet Aggregation Inhibitors; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2002 |
Peroxisome proliferators compete and ameliorate Hcy-mediated endocardial endothelial cell activation.
Topics: Animals; Binding, Competitive; Cells, Cultured; Clofibric Acid; Dose-Response Relationship, Drug; Endocardium; Endothelium, Vascular; Fibric Acids; Homocysteine; Intercellular Adhesion Molecule-1; Ligands; Matrix Metalloproteinases; Mice; Myocardium; Prostaglandin D2; Protein Conformation; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2002 |